-
2
-
-
0028055214
-
Controlled evaluation of three drug combination regimens versus fluorouracil alone for the therapy for advanced gastric cancer
-
Cullinan SA, Moertel CG, Wieand HS, et al. Controlled evaluation of three drug combination regimens versus fluorouracil alone for the therapy for advanced gastric cancer. J Clin Oncol 1994; 12: 412-6.
-
(1994)
J Clin Oncol
, vol.12
, pp. 412-416
-
-
Cullinan, S.A.1
Moertel, C.G.2
Wieand, H.S.3
-
3
-
-
0027217474
-
Modified therapy with 5-fluorouracil, doxorubicin and methotrexate in advanced gastric cancer
-
Murad AM, Santiago FF, Petroianu A, Rocha PRS, Rodrigues MAG, Rausch M. Modified therapy with 5-fluorouracil, doxorubicin and methotrexate in advanced gastric cancer. Cancer 1993; 72: 37-41.
-
(1993)
Cancer
, vol.72
, pp. 37-41
-
-
Murad, A.M.1
Santiago, F.F.2
Petroianu, A.3
Rocha, P.R.S.4
Rodrigues, M.A.G.5
Rausch, M.6
-
4
-
-
84944367593
-
A comparison of three chemotherapeutic regimens in the treatment of advanced pancreatic and gastric carcinoma
-
Cullinan S, Moertel C, Fleming T, Everson L, Krook J, Schutt A. A comparison of three chemotherapeutic regimens in the treatment of advanced pancreatic and gastric carcinoma. JAMA 1985; 253: 2062-7.
-
(1985)
JAMA
, vol.253
, pp. 2062-2067
-
-
Cullinan, S.1
Moertel, C.2
Fleming, T.3
Everson, L.4
Krook, J.5
Schutt, A.6
-
5
-
-
0027198871
-
A phase III randomised study of 5-fluorouracil and cisplatin versus 5-fluorouracil, doxorubicin and mitomycin-C versus 5-fluorouracil alone in the treatment of advanced gastric cancer
-
Kim NK, Park YS, Heo DS, et al. A phase III randomised study of 5-fluorouracil and cisplatin versus 5-fluorouracil, doxorubicin and mitomycin-C versus 5-fluorouracil alone in the treatment of advanced gastric cancer. Cancer 1993; 71: 3813-8.
-
(1993)
Cancer
, vol.71
, pp. 3813-3818
-
-
Kim, N.K.1
Park, Y.S.2
Heo, D.S.3
-
6
-
-
0025213358
-
High-dose folinic acid/ etoposide/5-fluorouracil in advanced gastric cancer - A phase II study in elderly patients or patients with cardiac risk
-
Wilke H, Preusser P, Achterrath W, et al. High-dose folinic acid/ etoposide/5-fluorouracil in advanced gastric cancer - a phase II study in elderly patients or patients with cardiac risk. Invest New Drugs 1990; 8 : 65-70.
-
(1990)
Invest New Drugs
, vol.8
, pp. 65-70
-
-
Wilke, H.1
Preusser, P.2
Achterrath, W.3
-
7
-
-
0004574948
-
Etoposide, leucovorin and fluorouracil (ELF) regimen in thetreatment of advanced gastric cancer AGO: An Italian Trials in Medical Oncology study
-
de Braud F, Bajetta E, Di Bartolomeo M, Buzzoni R. Etoposide, leucovorin and fluorouracil (ELF) regimen in thetreatment of advanced gastric cancer (AGO: an Italian Trials in Medical Oncology study. Proc Am Soc Clin Oncol 1993: 12; 210.
-
(1993)
Proc Am Soc Clin Oncol
, vol.12
, pp. 210
-
-
De Braud, F.1
Bajetta, E.2
Di Bartolomeo, M.3
Buzzoni, R.4
-
8
-
-
0025022482
-
New developments in the treatment of gastric carcinoma
-
Wilke H, Preusser P, Fink U, et al. New developments in the treatment of gastric carcinoma. Semin Oncol 1990; 17 (1 suppl 2): 61-70.
-
(1990)
Semin Oncol
, vol.17
, Issue.1-2 SUPPL.
, pp. 61-70
-
-
Wilke, H.1
Preusser, P.2
Fink, U.3
-
9
-
-
0342492981
-
5-fluorouracil,adriamycin and methotrexate - A combination protocol (FAMTX) for treatment of metastasized stomach cancer
-
Klein HO, Wickramanayake PD, Farrkh GR. 5-fluorouracil,adriamycin and methotrexate - a combination protocol (FAMTX) for treatment of metastasized stomach cancer. Proc Am Soc Clin Oncol 1986; 84: 86.
-
(1986)
Proc Am Soc Clin Oncol
, vol.84
, pp. 86
-
-
Klein, H.O.1
Wickramanayake, P.D.2
Farrkh, G.R.3
-
10
-
-
0009321083
-
Phase II trial of VP-16, leucovorin and fluorouracil (ELF) in advanced gastric carcinoma
-
Geffen JR, Venook AP, Luce J, et al. Phase II trial of VP-16, leucovorin and fluorouracil (ELF) in advanced gastric carcinoma. Proc Am Soc Clin Oncol 1992; 11: 195.
-
(1992)
Proc Am Soc Clin Oncol
, vol.11
, pp. 195
-
-
Geffen, J.R.1
Venook, A.P.2
Luce, J.3
|